Paper

Taxifolin improves disorders of glucose metabolism and water-salt metabolism in kidney via PI3K/AKT signaling pathway in metabolic syndrome rats.

Published Nov 3, 2020 · Liyuan Gao, Peipei Yuan, Qi Zhang

Life sciences

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCTAnimal Study

Study Snapshot

Taxifolin improves glucose metabolism, reduces inflammatory response, and reduces blood pressure in metabolic syndrome rats by targeting the PI3K/AKT signaling pathway.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Taxifolin improves disorders of glucose metabolism and water-salt metabolism in kidney via PI3K/AKT signaling pathway in metabolic syndrome rats.

References

Citations